Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Benchmark Appoints Dechra Pharma Director As Chief Financial Officer

14th Aug 2019 15:15

(Alliance News) - Aquaculture genetics firm Benchmark Holdings PLC said Wednesday it has appointed Septima Maguire as chief financial officer with effect in November.

She will be replacing Mark Plampin, who will remain in the company until January to ensure an effective transition.

Plampin has been CFO at Benchmark for nine years since 2010.

Maguire will be joining from FTSE 250-listed Dechra Pharmaceuticals PLC, which she was part of for four years since 2015, leaving as corporate development director, overseeing acquisition activities, strategic projects and business development.

Prior to Dechra, Maguire was part of Luxembourg-based packaging firm Ardagh Group SA for six years from 2008 to 2014.

"We are delighted to have recruited someone of Septima's calibre. She has extensive strategic, investor and operational finance experience and proven expertise in driving improved business performance. She will be a valuable member of the leadership team as we focus on implementing structural and operational efficiencies and delivering on our five year strategy to drive future growth and profitability," said Chief Executive Officer Malcolm Pye.

Shares in Benchmark Holdings were up 2.4% at 42.00 pence on Wednesday.


Related Shares:

Benchmark HoldingsDPH.L
FTSE 100 Latest
Value8,809.74
Change53.53